日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

p21 regulates expression of ECM components and promotes pulmonary fibrosis via CDK4 and Rb

p21通过CDK4和Rb调节ECM成分的表达并促进肺纤维化。

Nurit Papismadov ,Naama Levi ,Lior Roitman ,Amit Agrawal ,Yossi Ovadya ,Ulysse Cherqui ,Reut Yosef ,Hagay Akiva ,Hilah Gal ,Valery Krizhanovsky

Impaired immune surveillance accelerates accumulation of senescent cells and aging

免疫监视功能受损会加速衰老细胞的积累和衰老过程。

Yossi Ovadya ,Tomer Landsberger ,Hanna Leins ,Ezra Vadai ,Hilah Gal ,Anat Biran ,Reut Yosef ,Adi Sagiv ,Amit Agrawal ,Alon Shapira ,Joseph Windheim ,Michael Tsoory ,Reinhold Schirmbeck ,Ido Amit ,Hartmut Geiger ,Valery Krizhanovsky

p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling

p21通过抑制JNK和caspase信号通路,在持续的DNA损伤反应下维持衰老细胞的活力。

Reut Yosef ,Noam Pilpel ,Nurit Papismadov ,Hilah Gal ,Yossi Ovadya ,Ezra Vadai ,Stav Miller ,Ziv Porat ,Shifra Ben-Dor ,Valery Krizhanovsky

Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL

通过抑制 BCL-W 和 BCL-XL 定向清除衰老细胞

Reut Yosef ,Noam Pilpel ,Ronit Tokarsky-Amiel ,Anat Biran ,Yossi Ovadya ,Snir Cohen ,Ezra Vadai ,Liat Dassa ,Elisheva Shahar ,Reba Condiotti ,Ittai Ben-Porath ,Valery Krizhanovsky

'Multi-epitope-targeted' immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptides

通过工程化多表位蛋白对多发性硬化症样疾病进行“多表位靶向”免疫特异性治疗优于肽类疗法

Nathali Kaushansky, Nicole Kerlero de Rosbo, Rina Zilkha-Falb, Reut Yosef-Hemo, Lydia Cohen, Avraham Ben-Nun